Pharma Times
SEPTEMBER 28, 2021
Informa Pharma Intelligence (IPI) has found that some drug firms may withdraw up to 90% of their products from Northern Ireland, once the Brexit grace period has passed.
NY Times
OCTOBER 1, 2021
The drug maker will seek authorization for molnupiravir, the first drug of its kind for Covid. Experts said such pills could be a powerful tool against the virus.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
SEPTEMBER 29, 2021
Amazon’s push into healthcare takes many forms, and one is decidedly biotech-like – running an accelerator to identify and support startups with promising technology platforms. The online commerce giant’s first accelerator kicked off in June, focusing on digital health companies, and 427 applications from 31 countries around the world have now been winnowed down to 10 finalists.
Outsourcing Pharma
SEPTEMBER 30, 2021
A study by Charles River finds patients believe the overall quality of healthcare would increase if stakeholders across the life sciences collaborated more.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharma Times
OCTOBER 1, 2021
The European Patent Office (EPO) has granted a patent to specialist pharmaceutical company, N4 Pharma, for its Nuvec cancer treatment and vaccine delivery system.
NY Times
OCTOBER 1, 2021
The drug maker will seek authorization for molnupiravir, the first drug of its kind for Covid. Experts said such pills could be a powerful tool against the virus.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Outsourcing Pharma
SEPTEMBER 28, 2021
Conducted by patient services specialist Greenphire, the survey checks in with contract research organizations and shows how they are approaching obstacles.
Pharma Times
SEPTEMBER 29, 2021
According to a report from the Association of the British Pharmaceutical Industry (ABPI), the UK is taking longer to recover from the COVID-19 pandemic than its European peers.
NY Times
SEPTEMBER 28, 2021
The finding came from a study of Americans who got their third vaccine dose in August and September, and provided a reassuring sign about the safety of additional doses.
pharmaphorum
SEPTEMBER 29, 2021
A research project between Bayer and digital health company Huma will use artificial intelligence to detect lung cancer in CT scans – and determine which type a patient has, in order to direct treatment. AI is already being applied by a number of groups, with some studies indicating it can even be more effective than trained radiologists in detecting subtle patterns that indicate the presence of tumours.
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
Outsourcing Pharma
SEPTEMBER 27, 2021
The protease inhibitor PF-07321332 (co-administered with ritonavir) is designed for patients exposed to (or showing the first signs of) the COVID-19 virus.
Pharma Times
SEPTEMBER 28, 2021
Sanome, an early-stage biotech company based in London and Cambridge, has received support from health and biotech investors from the UK and Europe in its first round of funding.
NY Times
SEPTEMBER 27, 2021
A growing number of cancer patients, especially those with breast and lung cancers, are being spared the dreaded treatment in favor of other options.
pharmaphorum
SEPTEMBER 29, 2021
Oliver Stohlmann’s Corporate Survival Hacks series draws on his experiences of working in local, regional and global life science communications to offer some little tips for enjoying a big business career. In this column he addresses the appropriate use of email and how to avoid nightmares in electronic communication. “My fiancée had bought me a string tanga birthday present.
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
Outsourcing Pharma
SEPTEMBER 28, 2021
The pharmaceutical firm has tapped the decentralized research organization in order to help elevate the inclusivity of its oncology trials at all levels.
Pharma Times
SEPTEMBER 30, 2021
Glenmark Pharmaceuticals has announced that it has received marketing approval for its fixed-dose combination nasal spray, Ryaltris, in 13 countries across the UK and EU.
NY Times
SEPTEMBER 26, 2021
Calls to poison control centers have soared across the country as misinformation spreads touting the anti-parasite drug as a Covid treatment.
pharmaphorum
SEPTEMBER 27, 2021
Takeda has chalked up another milestone for its Alofisel cell therapy for a complication of Crohn’s disease, becoming the first allogeneic stem cell therapy to be approved in Japan. Alofisel (darvadstrocel) has been cleared by the Ministry of Health, Labour and Welfare (MHLW) for the treatment of complex perianal fistulas in patients with non-active or mildly active luminal Crohn’s disease who have not responded to conventional therapies.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Outsourcing Pharma
OCTOBER 1, 2021
The pharma firm reports molnupiravir was shown to cut risk of hospitalization or death by 50% compared to placebos in a positive interim Phase III analysis.
Pharma Times
SEPTEMBER 29, 2021
ViiV Healthcare, global specialist HIV company owned by GlaxoSmithKline (GSK), has announced an exclusive collaboration with Shionogi & Co Ltd (Shionogi) to develop a third-generation HIV integrase inhibitor (INSTI), with potential for ultra-long-acting dosing intervals.
NY Times
SEPTEMBER 28, 2021
Veterinarians, ranchers and farmers say they are struggling with the effects of the surging demand for ivermectin, a deworming drug.
pharmaphorum
SEPTEMBER 28, 2021
Prospects for Valneva’s COVID-19 vaccine are up in the air, but another candidate partnered with Pfizer looks increasingly like it could fill the void of an effective shot for Lyme disease. New phase 2 data with their VLA15 vaccine shows that antibody responses from an initial three-dose regimen are initially high, although they start to decline after 18 months in adult subjects.
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
Outsourcing Pharma
SEPTEMBER 28, 2021
Q BioMed reports it expects candidate MAN-19, intended to treat COVID-19-related Acute Respiratory Distress Syndrome, to enter trials early next year.
Pharma Times
OCTOBER 1, 2021
The interim results from Aberdeen-born 4D Pharma revealed that the first half of 2021 was a “significant period” for the biotechnology firm, according Proactive.
NY Times
OCTOBER 1, 2021
The pills are effective and relatively cheap, but they are unlikely to be available for everyone with Covid.
pharmaphorum
SEPTEMBER 27, 2021
As people have become more conscious and vocal about diversity and inclusion, Page & Page’s Lisa Lishman says pharma should reassess how it conducts clinical trials. The pharmaceutical industry is one of the most important industries in the world, providing lifesaving drugs and treatment to people who need it the most. This already significant industry is growing – it is estimated to be worth $1.27 trillion by end of 2020.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Drug Patent Watch
SEPTEMBER 26, 2021
This chart shows the drugs with the most patents in Ukraine. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…. The post Which pharmaceutical drugs have the most drug patents in Ukraine? appeared first on DrugPatentWatch - Make Better Decisions.
Pharma Times
SEPTEMBER 30, 2021
People with advanced or metastatic urothelial cancer will soon have access to a new treatment option following a NICE recommendation.
NY Times
OCTOBER 1, 2021
The pills are effective and relatively cheap, but they are unlikely to be available for everyone with Covid.
pharmaphorum
SEPTEMBER 28, 2021
Sanofi has said that it won’t develop its mRNA-based vaccine for COVID-19 any further, even though it seemed to work in an early-stage trial, and will focus instead on another candidate partnered with GlaxoSmithKline. The French pharma group said it took the decision because mRNA vaccines from Pfizer/BioNTech and Moderna are already widely available today it will be too late to the market with its candidate, which was originated by its partner Translate Bio.
Drug Channels
OCTOBER 1, 2021
Today’s guest post comes from David Fidler, Senior Director of Product Innovation at ConnectiveRx. David discusses how electronic prior authorization (ePA) and first-fill, buy-down programs can boost patient adherence to specialty therapies. On November 3rd at 1:00 pm ET, ConnectiveRx will host First Fill, No Wait: How to Make it Happen , a free webinar about copay ePA.
Expert insights. Personalized for you.
153 
Let's personalize your content